Advances in Melanoma and Skin Cancers
Open Access
- 21 February 2025
- journal article
- editorial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1849
Abstract
Cutaneous melanoma, with a continuously rising incidence worldwide, represents one of the most aggressive forms of skin cancerKeywords
This publication has 23 references indexed in Scilit:
- Recent advances in immunotherapy and its combination therapies for advanced melanoma: a reviewFrontiers in Oncology, 2024
- Novel liquid biopsy CNV biomarkers in malignant melanomaScientific Reports, 2024
- Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsyPeriodontology 2000, 2024
- Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the FieldCancers, 2023
- Immunotherapy in Melanoma: Recent Advances and Future DirectionsCancers, 2023
- Evaluation of cell-free DNA approaches for multi-cancer early detectionCancer Cell, 2022
- Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced MelanomaJournal of Clinical Oncology, 2022
- Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanomaEuropean Journal of Cancer, 2020
- Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of CancerMolecular Cancer Research, 2020
- Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With NivolumabJAMA Oncology, 2019